COVID-19: Molecular and Cellular Response

Front Cell Infect Microbiol. 2021 Feb 11:11:563085. doi: 10.3389/fcimb.2021.563085. eCollection 2021.

Abstract

In late December 2019, a vtiral pneumonia with an unknown agent was reported in Wuhan, China. A novel coronavirus was identified as the causative agent. Because of the human-to-human transmission and rapid spread; coronavirus disease 2019 (COVID-19) has rapidly increased to an epidemic scale and poses a severe threat to human health; it has been declared a public health emergency of international concern (PHEIC) by the World Health Organization (WHO). This review aims to summarize the recent research progress of COVID-19 molecular features and immunopathogenesis to provide a reference for further research in prevention and treatment of SARS coronavirus2 (SARS-CoV-2) infection based on the knowledge from researches on SARS-CoV and Middle East respiratory syndrome-related coronavirus (MERS-CoV).

Keywords: ACE2; COVID-19; IL-6; IL-8; cytokines.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptive Immunity
  • Angiotensin-Converting Enzyme 2 / metabolism
  • COVID-19 / immunology
  • COVID-19 / metabolism*
  • COVID-19 / virology*
  • Cytokines / immunology
  • Cytokines / metabolism
  • Humans
  • Immunity, Innate
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / pathogenicity*
  • SARS-CoV-2 / physiology
  • Spike Glycoprotein, Coronavirus / metabolism
  • Virus Internalization

Substances

  • Cytokines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2